A Scintigraphy Study in Adults With Diabetic Gastroparesis

Status Terminated

Clinical Trial Summary

This is a randomized, double-blind, placebo-controlled scintigraphy study to investigate the effect of oral CIN-102 on gastric emptying and antral contractility in adults with diabetic gastroparesis.

Clinical Trial Description

This is a randomized, double-blind, placebo-controlled scintigraphy study to investigate the effect of oral CIN-102 on gastric emptying and antral contractility in adults with diabetic gastroparesis. The population for this study is adult patients 18 to 70 years old with Type 1 or Type 2 diabetes and a diagnosis of diabetic gastroparesis. The study will consist of two cohorts with approximately 15 subjects in each cohort. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04208698
Study type	Interventional
Source	CinDome Pharma, Inc.
Contact
Status	Terminated
Phase	Phase 2
Start date	February 17, 2020
Completion date	March 31, 2020

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01557296` - Evaluation of Diagnostic Methods and Dietary Treatment of Diabetic Gastroparesis	Phase 2
Withdrawn	`NCT03376399` - Potential Benefits of Sleeve Gastrectomy Surgery on Diabetic Gastroparesis Symptoms
Not yet recruiting	`NCT02264587` - Effects and Mechanism of Mosapride Citrate on Diabetic Gastroparesis	Phase 4
Completed	`NCT02289846` - Trial of IW-9179 in Patients With Diabetic Gastroparesis (DGP)	Phase 2
Completed	`NCT03544229` - A Study to Evaluate the Efficacy and Safety of TAK-906 in Adult Participants With Symptomatic Idiopathic or Diabetic Gastroparesis	Phase 2
Recruiting	`NCT04706832` - Thoracic Splanchnic Magnetic Neuromodulation Therapy (ThorS-MagNT) for Grade 3 Diabetic Gastroparesis: Pilot Study	N/A
Not yet recruiting	`NCT05584462` - Gastroparesis in type2 Diabetic Patient
Enrolling by invitation	`NCT05812339` - Body Surface Gastric Mapping to Evaluate Patients With Upper Gastrointestinal Symptoms and Controls
Completed	`NCT02732821` - G-POEM for Treatment of Refractory Gastroparesis
Completed	`NCT01030341` - Continuous Glucose Monitoring and Insulin Pump Therapy in Diabetic Gastroparesis	N/A
Recruiting	`NCT05832151` - A Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adults With Diabetic Gastroparesis	Phase 2
Completed	`NCT02025725` - Multicenter Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray in Women With Diabetic Gastroparesis	Phase 3
Completed	`NCT01916460` - Intraluminal Endosonography for Examination of the Structural Changes of the Stomach in Gastroparetic Patients	N/A
Completed	`NCT01469286` - Transcutaneous Electroacupuncture for Gastroparesis	Phase 1
Terminated	`NCT00874133` - The Effect of Acupuncture on Symptoms, Gastric Emptying Rate and Glucose Control in Patients With Diabetic Gastroparesis	N/A
Completed	`NCT01126034` - Improving Metoclopramide Prescribing Practices at Penn Through a Physician-targeted Intervention	N/A
Recruiting	`NCT05273788` - Thoracic Neuromodulation for Diabetic Gastroparesis	N/A
Suspended	`NCT00470795` - Acupuncture for Diabetic Gastroparesis	Phase 3
Completed	`NCT00139893` - A Randomized, Open-label, Two-way Crossover Trial to Determine the Pharmacokinetics of Metoclopramide When Administered as the Orally Disintegrating Tablet Compared to Reglan® Tablets in Subjects With Diabetic Gastroparesis	N/A
Recruiting	`NCT04254549` - Rifaximin in Patients With Diabetic Gastroparesis	Phase 2